Filing Details
- Accession Number:
- 0001209191-14-046570
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-07-09 17:37:40
- Reporting Period:
- 2014-07-08
- Filing Date:
- 2014-07-09
- Accepted Time:
- 2014-07-09 17:37:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1245104 | Globeimmune Inc | GBIM | Pharmaceutical Preparations (2834) | 841353925 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1113661 | J Daniel Mitchell | C/O Sequel Limited Partnership Iii 4430 Arapahoe Avenue, Suite 220 Boulder CO 80303 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-07-08 | 6,961 | $0.00 | 6,961 | No | 4 | C | Indirect | By Sequel Entrepreneurs Fund III, LP |
Common Stock | Acquisiton | 2014-07-08 | 250,645 | $0.00 | 250,645 | No | 4 | C | Indirect | By Sequel Limited Partnership III |
Common Stock | Acquisiton | 2014-07-08 | 75,000 | $10.00 | 325,645 | No | 4 | P | Indirect | By Sequel Limited Partnership III |
Common Stock | Acquisiton | 2014-07-08 | 10,000 | $10.00 | 10,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | By Sequel Entrepreneurs Fund III, LP |
No | 4 | C | Indirect | By Sequel Limited Partnership III |
No | 4 | P | Indirect | By Sequel Limited Partnership III |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Convertible Preferred Stock | Disposition | 2014-07-08 | 36,557 | $0.00 | 1,162 | $0.00 |
Common Stock | Series A Convertible Preferred Stock | Disposition | 2014-07-08 | 1,315,441 | $0.00 | 41,904 | $0.00 |
Common Stock | Series B Convertible Preferred Stock | Disposition | 2014-07-08 | 84,879 | $0.00 | 2,704 | $0.00 |
Common Stock | Series B Convertible Preferred Stock | Disposition | 2014-07-08 | 3,054,134 | $0.00 | 97,296 | $0.00 |
Common Stock | Series C Convertible Preferred Stock | Disposition | 2014-07-08 | 75,318 | $0.00 | 2,398 | $0.00 |
Common Stock | Series C Convertible Preferred Stock | Disposition | 2014-07-08 | 2,710,122 | $0.00 | 86,335 | $0.00 |
Common Stock | Series E Convertible Preferred Stock | Disposition | 2014-07-08 | 21,905 | $0.00 | 697 | $0.00 |
Common Stock | Series E Convertible Preferred Stock | Disposition | 2014-07-08 | 788,205 | $0.00 | 25,110 | $0.00 |
Common Stock | Warrant to Purchase Series B Preferred Stock (right to buy) | Disposition | 2014-07-08 | 2,334 | $1.34 | 2,334 | $0.00 |
Common Stock | Warrant to Purchase Series B Preferred Stock (right to buy) | Disposition | 2014-07-08 | 83,988 | $1.34 | 83,988 | $0.00 |
Common Stock | Warrant to Purchase Series C Preferred Stock (right to buy) | Disposition | 2014-07-08 | 1,860 | $1.45 | 1,860 | $0.00 |
Common Stock | Warrant to Purchase Series C Preferred Stock (right to buy) | Disposition | 2014-07-08 | 66,955 | $1.45 | 66,955 | $0.00 |
Common Stock | Warrant to Purchase Common Stock (right to buy) | Acquisiton | 2014-07-08 | 74 | $0.00 | 74 | $42.00 |
Common Stock | Warrant to Purchase Common Stock (right to buy) | Acquisiton | 2014-07-08 | 2,675 | $0.00 | 2,675 | $42.00 |
Common Stock | Warrant to Purchase Common Stock (right to buy) | Acquisiton | 2014-07-08 | 59 | $0.00 | 59 | $45.36 |
Common Stock | Warrant to Purchase Common Stock (right to buy) | Acquisiton | 2014-07-08 | 2,133 | $0.00 | 2,133 | $45.36 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
74 | No | 4 | C | Indirect | ||
2,675 | No | 4 | C | Indirect | ||
59 | No | 4 | C | Indirect | ||
2,133 | No | 4 | C | Indirect |
Footnotes
- Represents shares of common stock of the Issuer received upon conversion of shares of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock, and Series E Convertible Stock.
- Every one share of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock, and Series E Convertible Stock (collectively, the "Convertible Preferred Stock") converted on a 1-for- 31.39 basis into shares of common stock of the Issuer upon the closing of the Issuer's initial public offering. The Convertible Preferred Stock of the Issuer had no expiration and was convertible at any time at the option of the holder.
- Each one share of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock converted on a 1-for-31.39 share basis into shares of common stock of the Issuer upon the closing of the Issuer's initial public offering. The number of shares and price per share reported herein does not reflect such conversion. The Warrant was immediately exercisable at any time at the option of the holder.
- Represents warrants to purchase shares of common stock of the Issuer following the conversion of the Series B Convertible Preferred Stock and Series C Convertible Preferred Stock on a 1-for-31.39 share basis. The number of shares and price per share reported herein reflects such conversion. The Warrant is immediately exercisable at any time at the option of the holder.
- The general partner of the Sequel Entrepreneurs Fund III, L.P. and Sequel Limited Partnership III (collectively, the "Sequel Funds") is Sequel Venture Partners III, L.L.C. ("SVP III"). SVP III may be deemed to indirectly beneficially own the shares owned by the Sequel Funds. The Reporting Person is a manager of SVP III and may be deemed to be the indirect beneficial owner of the shares owned by the Sequel Funds. The Reporting Person disclaims beneficial ownership of the shares held by the Sequel Funds, except to the extent of his pecuniary interest arising therein.